Bank of New York Mellon’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-661,157
| Closed | -$109M | – | 4610 |
|
|
2021
Q2 | $109M | Sell |
661,157
-23,589
| -3% | -$3.94M | 0.02% | 663 |
|
|
2021
Q1 | $105M | Buy |
684,746
+28,941
| +4% | +$3.93M | 0.02% | 674 |
|
|
2020
Q4 | $82.3M | Sell |
655,805
-17,841
| -3% | -$2M | 0.02% | 744 |
|
|
2020
Q3 | $68.3M | Sell |
673,646
-76,269
| -10% | -$7.78M | 0.02% | 732 |
|
|
2020
Q2 | $73M | Buy |
749,915
+71,166
| +10% | +$6.62M | 0.02% | 682 |
|
|
2020
Q1 | $56.4M | Sell |
678,749
-3,998
| -0.6% | -$390K | 0.02% | 707 |
|
|
2019
Q4 | $75.9M | Sell |
682,747
-403,542
| -37% | -$41.5M | 0.02% | 739 |
|
|
2019
Q3 | $108M | Sell |
1,086,289
-534,619
| -33% | -$53.1M | 0.03% | 555 |
|
|
2019
Q2 | $161M | Buy |
1,620,908
+102,641
| +7% | +$9.8M | 0.04% | 391 |
|
|
2019
Q1 | $167M | Sell |
1,518,267
-669,623
| -31% | -$70M | 0.05% | 372 |
|
|
2018
Q4 | $201M | Sell |
2,187,890
-277,357
| -11% | -$28.1M | 0.06% | 281 |
|
|
2018
Q3 | $272M | Buy |
2,465,247
+268,243
| +12% | +$27.9M | 0.07% | 265 |
|
|
2018
Q2 | $205M | Buy |
2,197,004
+673,202
| +44% | +$58M | 0.06% | 336 |
|
|
2018
Q1 | $126M | Buy |
1,523,802
+611,974
| +67% | +$54.4M | 0.04% | 489 |
|
|
2017
Q4 | $83M | Buy |
911,828
+592,595
| +186% | +$49.3M | 0.02% | 731 |
|
|
2017
Q3 | $24.3M | Buy |
319,233
+65,887
| +26% | +$4.98M | 0.01% | 1447 |
|
|
2017
Q2 | $19M | Buy |
253,346
+34,856
| +16% | +$2.42M | 0.01% | 1580 |
|
|
2017
Q1 | $14.3M | Buy |
218,490
+14,059
| +7% | +$828K | ﹤0.01% | 1762 |
|
|
2016
Q4 | $11.3M | Buy |
204,431
+11,516
| +6% | +$632K | ﹤0.01% | 1898 |
|
|
2016
Q3 | $10.9M | Buy |
192,915
+19,094
| +11% | +$936K | ﹤0.01% | 1835 |
|
|
2016
Q2 | $7.26M | Buy |
173,821
+33,229
| +24% | +$1.53M | ﹤0.01% | 2017 |
|
|
2016
Q1 | $6.01M | Buy |
140,592
+8,151
| +6% | +$344K | ﹤0.01% | 2085 |
|
|
2015
Q4 | $6M | Buy |
132,441
+12,704
| +11% | +$534K | ﹤0.01% | 2121 |
|
|
2015
Q3 | $4.65M | Sell |
119,737
-7,569
| -6% | -$303K | ﹤0.01% | 2276 |
|
|
2015
Q2 | $4.63M | Buy |
127,306
+46,761
| +58% | +$1.48M | ﹤0.01% | 2399 |
|
|
2015
Q1 | $2.32M | Buy |
80,545
+12,106
| +18% | +$338K | ﹤0.01% | 2757 |
|
|
2014
Q4 | $1.66M | Buy |
+68,439
| New | +$1.54M | ﹤0.01% | 2991 |
|
Other funds holding PRAH
Bank of New York Mellon's PRAH Position: Q3 2021 in Review
Bank of New York Mellon sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 661,157 shares — an estimated $109M sold.
Bank of New York Mellon first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $272M in Q3 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Bank of New York Mellon reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Bank of New York Mellon sold 661,157 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $109M.
- Bank of New York Mellon first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- Bank of New York Mellon's PRA Health Sciences, Inc. position peaked at $272M in Q3 2018.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.